Mouse Model of Lymph Node Metastasis via Afferent Lymphatic Vessels for Development of Imaging Modalities

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Li, Li ^a,b   Mori, Shiro ^c   Sakamoto, Maya ^a   Takahashi, Shoki ^b   Kodama, Tetsuya ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AFFERENT LYMPH VESSEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXILLARY LYMPH NODE; BIOLUMINESCENCE; BLOOD VESSEL DENSITY; BLOOD VESSEL PARAMETERS; BLOOD VESSEL VOLUME; CANCER DIAGNOSIS; CANCER GROWTH; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; ECHOGRAPHY; EX VIVO STUDY; IN VIVO STUDY; LYMPH NODE; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHADENOPATHY; MOUSE; NONHUMAN; SIGNAL DETECTION; SUBILIAC LYMPH NODE; THREE DIMENSIONAL CONTRAST ENHANCED HIGH FREQUENCY ULTRASOUND IMAGING; THREE DIMENSIONAL IMAGING;

ANIMALS; AXILLA; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUCIFERASES; LUMINESCENT MEASUREMENTS; LYMPH NODES; LYMPHATIC DISEASES; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MICE; MICE, INBRED MRL LPR;

EID: 84873546384     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055797     Document Type: Article

References (52)

1. Roitt I, Brostoff J, Male D (2001) Immunology. Edinburgh: Mosby.
2. Warwick, Roger; Peter L Williams (1973) [1858]. Angiology, Chapter 6. Gray's anatomy. illustrated by Richard E. M. Moore (Thirty-fifth ed.). London: Longman. p. 588-785.
3. Ran S, Volk L, Hall K, Flister MJ, (2010) Lymphangiogenesis and lymphatic metastasis in breast cancer. Pathophysiology 17: 229-251.
4. Ito Y, Nakanishi H, Kodera Y, Hirai T, Nakao A, et al. (2010) Characterization of a novel lymph node metastasis model from human colonic cancer and its preclinical use for comparison of anti-metastatic efficacy between oral S-1 and UFT/LV. Cancer Sci. 101(8): 1853-1860.
5. Lutman CV, Havrilesky LJ, Cragun JM, Secord AA, Calingaert B, et al. (2006) Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Gynecol Oncol 102: 92-97.
6. Burton JB, Johnson M, Sato M, Koh SB, Mulholland DJ, et al. (2008) Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer. Nat Med 14: 882-888.
7. Servais EL, Colovos C, Bograd AJ, White J, Sadelain M, et al. (2011) Animal models and molecular imaging tools to investigate lymph node metastases. J Mol Med (Berl) 89: 753-769.
8. Khanna C, Hunter K, (2005) Modeling metastasis in vivo. Carcinogenesis 26: 513-523.
9. Graham KC, Wirtzfeld LA, MacKenzie LT, Postenka CO, Groom AC, et al. (2005) Three-dimensional high-frequency ultrasound imaging for longitudinal evaluation of liver metastases in preclinical models. Cancer Res 65: 5231-5237.
10. Kasuya H, Kuruppu DK, Donahue JM, Choi EW, Kawasaki H, et al. (2005) Mouse models of subcutaneous spleen reservoir for multiple portal venous injections to treat liver malignancies. Cancer Res 65: 3823-3827.
11. Nathanson SD, (2007) Preclinical models of regional lymph node tumor metastasis. Cancer Treat Res 135: 129-156.
12. Kozaki K, Miyaishi O, Tsukamoto T, Tatematsu Y, Hida T, et al. (2000) Establishment and characterization of a human lung cancer cell line NCI-H460-LNM35 with consistent lymphogenous metastasis via both subcutaneous and orthotopic propagation. Cancer Res 60: 2535-2540.
13. Doki Y, Murakami K, Yamaura T, Sugiyama S, Misaki T, et al. (1999) Mediastinal lymph node metastasis model by orthotopic intrapulmonary implantation of Lewis lung carcinoma cells in mice. Br J Cancer 79: 1121-1126.
14. Dieter M, Schubert R, Hirnle P, (2003) Blue liposomes for identification of the sentinel lymph nodes in pigs. Lymphology 36: 39-47.
15. Soltesz EG, Kim S, Laurence RG, DeGrand AM, Parungo CP, et al. (2005) Intraoperative sentinel lymph node mapping of the lung using near-infrared fluorescent quantum dots. Ann Thorac Surg 79: 269-277; discussion 269-277.
16. Hayashi K, Jiang P, Yamauchi K, Yamamoto N, Tsuchiya H, et al. (2007) Real-time imaging of tumor-cell shedding and trafficking in lymphatic channels. Cancer Res 67: 8223-8228.
17. Huyn ST, Burton JB, Sato M, Carey M, Gambhir SS, et al. (2009) A potent, imaging adenoviral vector driven by the cancer-selective mucin-1 promoter that targets breast cancer metastasis. Clin Cancer Res 15: 3126-3134.
18. Swirski FK, Berger CR, Figueiredo JL, Mempel TR, von Andrian UH, et al. (2007) A near-infrared cell tracker reagent for multiscopic in vivo imaging and quantification of leukocyte immune responses. PLoS One 2: e1075.
19. Bibby MC, (2004) Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages. Eur J Cancer 40: 852-857.
20. Murphy ED, Roths JB (1978) Autoimmunity and lymphoproliferation: induction by mutant gene lpr, and acceleration by a male-associated factor in strain BXSB mice; Rose N, Bigazzi P, Warner L, editors. New York: Elsevier/North-Holland. p. 207-221.
21. Furukawa H, Kitazawa H, Kaneko I, Kikuchi K, Tohma S, et al. (2009) Mast cells inhibit CD8+ T cell-mediated rejection of a malignant fibrous histiocytoma-like tumor: Involvement of Fas-Fas ligand axis. Am J Immunol 5: 89-97.
22. Hasegawa H, Kohno M, Sasaki M, Inoue A, Ito MR, et al. (2003) Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice. Arthritis Rheum 48: 2555-2566.
23. Gyotoku Y, Abdelmoula M, Spertini F, Izui S, Lambert PH, (1987) Cryoglobulinemia induced by monoclonal immunoglobulin G rheumatoid factors derived from autoimmune MRL/MpJ-lpr/lpr mice. J Immunol 138: 3785-3792.
24. Dickson PV, Hamner B, Ng CY, Hall MM, Zhou J, et al. (2007) In vivo bioluminescence imaging for early detection and monitoring of disease progression in a murine model of neuroblastoma. J Pediatr Surg 42: 1172-1179.
25. Unno N, Suzuki M, Yamamoto N, Inuzuka K, Sagara D, et al. (2008) Indocyanine green fluorescence angiography for intraoperative assessment of blood flow: a feasibility study. Eur J Vasc Endovasc Surg 35: 205-207.
26. Kodama T, Tomita N, Horie S, Sax N, Iwasaki H, et al. (2010) Morphological study of acoustic liposomes using transmission electron microscopy. J Electron Microsc 59: 187-196.
27. Kodama T, Aoi A, Watanabe Y, Horie S, Kodama M, et al. (2010) Evaluation of transfection efficiency in skeletal muscle using nano/microbubbles and ultrasound. Ultrasound Med Biol 36: 1196-1205.
28. Kodama T, Tomita N, Yagishita Y, Horie S, Funamoto K, et al. (2011) Volumetric and angiogenic evaluation of antitumor effects with acoustic liposome and high-frequency ultrasound. Cancer Res 71: 6957-6964.
29. du Toit LC, Govender T, Pillay V, Choonara YE, Kodama T, (2011) Investigating the effect of polymeric approaches on circulation time and physical properties of nanobubbles. Pharm Res 28: 494-504.
30. Loveless ME, Li X, Huamani J, Lyshchik A, Dawant B, et al. (2008) A method for assessing the microvasculature in a murine tumor model using contrast-enhanced ultrasonography. J Ultrasound Med 27: 1699-1709.
31. Matsumura Y, Maeda H, (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46: 6387-6392.
32. Kiessling F, Le-Huu M, Kunert T, Thorn M, Vosseler S, et al. (2005) Improved correlation of histological data with DCE MRI parameter maps by 3D reconstruction, reslicing and parameterization of the histological images. Eur Radiol 15: 1079-1086.
33. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S, (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314-317.
34. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, et al. (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76: 969-976.
35. Nagata S, (1994) Apoptosis regulated by a death factor and its receptor: Fas ligand and Fas. Philos Trans R Soc Lond B Biol Sci 345: 281-287.
36. Thompson SC, (1974) The colony forming efficiency of single cells and cell aggregates from a spontaneous mouse mammary tumour using the lung colony assay. Br J Cancer 30: 332-336.
37. Rofstad EK, Tunheim SH, Mathiesen B, Graff BA, Halsor EF, et al. (2002) Pulmonary and lymph node metastasis is associated with primary tumor interstitial fluid pressure in human melanoma xenografts. Cancer Res 62: 661-664.
38. van Deurzen CH, de Boer M, Monninkhof EM, Bult P, van der Wall E, et al. (2008) Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node. J Natl Cancer Inst 100: 1574-1580.
39. Hansen NM, Grube B, Ye X, Turner RR, Brenner RJ, et al. (2009) Impact of micrometastases in the sentinel node of patients with invasive breast cancer. J Clin Oncol 27: 4679-4684.
40. Uribarrena-Amezaga R, Ortego J, Fuentes J, Raventos N, Parra P, et al. (2010) Prognostic value of lymph node micrometastasis in patients with colorectal cancer in Dukes stages A and B (T1-T4, N0, M0). Rev Esp Enferm Dig 102: 176-186.
41. de Boer M, van Deurzen CH, van Dijck JA, Borm GF, van Diest PJ, et al. (2009) Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med 361: 653-663.
42. de Boer M, van Dijck JA, Bult P, Borm GF, Tjan-Heijnen VC, (2010) Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases. J Natl Cancer Inst 102: 410-425.
43. Chen SL, Hoehne FM, Giuliano AE, (2007) The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Ann Surg Oncol 14: 3378-3384.
44. van den Brekel MW, Castelijns JA, Snow GB, (1998) The size of lymph nodes in the neck on sonograms as a radiologic criterion for metastasis: how reliable is it? AJNR Am J Neuroradiol 19: 695-700.
45. Castelijns JA, van den Brekel MW, (2001) Detection of lymph node metastases in the neck: radiologic criteria. AJNR Am J Neuroradiol 22: 3-4.
46. Williams AD, Cousins C, Soutter WP, Mubashar M, Peters AM, et al. (2001) Detection of pelvic lymph node metastases in gynecologic malignancy: a comparison of CT, MR imaging, and positron emission tomography. AJR Am J Roentgenol 177: 343-348.
47. Folkman J, (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6.
48. Poon RT, Ng IO, Lau C, Yu WC, Yang ZF, et al. (2002) Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study. J Clin Oncol 20: 1775-1785.
49. Hanahan D, Folkman J, (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364.
50. Folkman J, (1972) Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg 175: 409-416.
51. Toker C, (1963) Some observations on the deposition of metastatic carcinoma within cervical lymph nodes. Cancer 16: 364-374.
52. Vakoc BJ, Fukumura D, Jain RK, Bouma BE, (2012) Cancer imaging by optical coherence tomography: preclinical progress and clinical potential. Nat Rev Cancer 12: 363-368.